Role of Transrectal Ultrasonography in Prostate Cancer

被引:24
作者
Ghai, Sangeet [1 ,2 ]
Toi, Ants [1 ,2 ]
机构
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Hlth Network, Mt Sinai Hosp, Womens Coll Hosp, Joint Dept Med Imaging, Toronto, ON, Canada
关键词
Transrectal ultrasound; Prostate cancer; Screening; Targeted biopsy; CONTRAST-ENHANCED SONOGRAPHY; PREVIOUS NEGATIVE BIOPSY; REAL-TIME ELASTOGRAPHY; COLOR DOPPLER; NEEDLE-BIOPSY; GUIDED BIOPSY; DIAGNOSTIC PERFORMANCE; ENDORECTAL SONOGRAPHY; SATURATION BIOPSY; SYSTEMATIC BIOPSY;
D O I
10.1016/j.rcl.2012.08.007
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Transrectal ultrasound and ultrasound guided prostate biopsy is the current standard for detecting prostate cancer. Newer techniques such as elastography and contrast enhanced ultrasound may help in lesion detection and monitoring. Advances are occurring in several areas including multiparametric MRI, understanding of the nature of prostate cancer and new therapies including focal therapy and active surveillance. These changes are creating an increasing role for targeted biopsies following MRI and for use of MRI for treatment monitoring.
引用
收藏
页码:1061 / +
页数:14
相关论文
共 88 条
  • [1] PSA and hK2 in the diagnosis of prostate cancer
    Alapont Alacreu, J. M.
    Navarro Rosales, S.
    Budia Alba, A.
    Espana Furio, F.
    Morera Martinez, F.
    Jimenez Cruz, J. F.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2008, 32 (06): : 575 - 588
  • [2] Newer modalities of ultrasound imaging and treatment of the prostate
    Amiel, Gilad E.
    Slawin, Kevin M.
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2006, 33 (03) : 329 - +
  • [3] MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies
    Anastasiadis, Aristotelis G.
    Lichy, Matthias P.
    Nagele, Udo
    Kuczyk, Markus A.
    Merseburger, Axel S.
    Hennenlotter, Joerg
    Corvin, Stefan
    Sievert, Karl-Dietrich
    Claussen, Claus D.
    Stenzl, Arnulf
    Schlemmer, Heinz-Peter
    [J]. EUROPEAN UROLOGY, 2006, 50 (04) : 738 - 749
  • [4] Mortality Results from a Randomized Prostate-Cancer Screening Trial
    Andriole, Gerald L.
    Grubb, Robert L., III
    Buys, Saundra S.
    Chia, David
    Church, Timothy R.
    Fouad, Mona N.
    Gelmann, Edward P.
    Kvale, Paul A.
    Reding, Douglas J.
    Weissfeld, Joel L.
    Yokochi, Lance A.
    Crawford, E. David
    O'Brien, Barbara
    Clapp, Jonathan D.
    Rathmell, Joshua M.
    Riley, Thomas L.
    Hayes, Richard B.
    Kramer, Barnett S.
    Izmirlian, Grant
    Miller, Anthony B.
    Pinsky, Paul F.
    Prorok, Philip C.
    Gohagan, John K.
    Berg, Christine D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13) : 1310 - 1319
  • [5] Arsov C, 2012, ANTICANCER RES, V32, P1087
  • [6] Reassessing the diagnostic yield of saturation biopsy of the prostate
    Ashley, Richard A.
    Inman, Brant A.
    Routh, Jonathan C.
    Mynderse, Lance A.
    Gettman, Matthew T.
    Blute, Michael L.
    [J]. EUROPEAN UROLOGY, 2008, 53 (05) : 976 - 983
  • [7] Hereditary prostate cancer: Clinical aspects
    Bratt, O
    [J]. JOURNAL OF UROLOGY, 2002, 168 (03) : 906 - 913
  • [8] The role of color Doppler and staging biopsies in prostate cancer detection
    Bree, RL
    [J]. UROLOGY, 1997, 49 (3A) : 31 - 34
  • [9] Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation
    Bunting, PS
    DeBoer, G
    Choo, R
    Danjoux, C
    Klotz, L
    Fleshner, N
    [J]. CLINICAL BIOCHEMISTRY, 2002, 35 (06) : 471 - 475
  • [10] Campbell MF., 2007, CAMPBELL WALSH UROLO